Singleplex Immunoassay Market Overview

The global singleplex immunoassay market is also gathering momentum due to the rapid expansion of the biotechnology and pharmaceutical sector. Moreover, growing popularity of immunoassay in oncology and fast adoption of rental immunoassay analyzers are other important factors creating market opportunities. It is anticipated that prevalence of chronic disorders will rise further in the near future, which will influence singleplex immunoassay demand. The market is also being propelled by forces such as emphasis towards diagnostic testing, rising awareness regarding immunoassay and in government support. However, highly complex FDA norms and arrival of alternatives to some extent may hamper the market growth during the assessment period.

Global singleplex immunoassay market to find lucrative growth opportunities in the forthcoming years. Market Research Future (MRFR) reports that the market will expand at a CAGR of 8.4% between 2020 and 2027. Singleplex immunoassays have become common medical products in recent years. Western blotting or Enzyme-Linked Immunosorbent Assays (ELISA) has become a popular singleplex immunoassays as they are increasingly utilized to analysing extracellular proteins and multiple intracellular. Their use has also increased owing to advantages such as fast and high-through output in procedures such as gene expression quantification.

Immunoassays are highly adaptable which are designed to detect the binding of the specific antibody to the target analyte. Singleplex immunoassays are generally used to analyze multiple intracellular and extracellular proteins and gene expression quantification.Increased focus on application-specific signleplex immunoassay is also expected to favour the Singleplex Immunoassay Market during the forecast period. For example, Thermo Fisher Scientific’s developed a unique singleplex assay “QuantiGene Singleplex assay” to identify DNA or RNA volume using signal amplification.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6196

Singleplex Immunoassay Market Players

Luminex,Thermo Fisher Scientific,Illumina,Bio-Rad Laboratories,QIAGEN N.V,Abcam,Becton Dickinson and Company,Merck Life sciences,Agilent Technologies,Quanterix,Bio-Techne,Olink,Seegene,BioVendor,Others

Singleplex Immunoassay Market Regional Segmentation

The global singleplex immunoassay market consists of four regions: Americas, Europe, Asia Pacific and the Middle East Africa. Americas is expected to account for the largest market share owing to the presence of a large number of market players, increasing the prevalence of cancer, immunological diseases, and metabolic diseases. For instance, in 2017, the American Cancer Society estimated that approximately 1,688,780 new cancer cases were diagnosed in America. Europe is anticipated to hold the second position in the market owing to the increasing prevalence of chronic diseases, funding's provided by the government, and private organizations towards research development. Asia Pacific is the fastest growing region in the global singleplex immunoassay market owing to the growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure and increasing research development activities in the biotechnology sector, and rising healthcare expenditure. The Middle East and Africa are anticipated to grow steadily due to the presence of stringent government policies and poor economies, especially in the Africa region.

Singleplex Immunoassay Market Segmentation

The global singleplex immunoassay market is segmented on the basis of the product and service, type, technology, application, and end user. On the basis of the product and services, the market is classified as consumables, instruments, and others. The global singleplex immunoassay market on the basis of the type is segmented as protein-based assays, nucleic acid-based assays, cell-based assays and others. On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, and others. The global singleplex immunoassay market, by application, is segmented into research and development, clinical diagnostics, and others. The research and development are further segmented into drug discovery development and biomarker discovery and validation. The clinical diagnostics are further segmented into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, and metabolism endocrinology disorders. On the basis of the end user, the global singleplex immunoassay market is segmented as pharmaceutical biotechnology companies, hospitals research institutes, reference laboratories and others.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/singleplex-immunoassay-market-6196

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]